Police deployed at Mumbai office of Dr Zakir Naik as precautionary measure

Mangaluru, Apr 6: The city police were seen wearing personal protective equipment including eye protection on Monday, April while on lockdown duty to slow the spread of COVID-19.

City police Commissioner Harsha taking to twitter wrote, ''Specialised protection equipment, AntiContagion face shields have been issued to all policemen at the front line having the highest risk of exposure to coronavirus..
They are fighting a pandemic .. FOR YOU..Be kind to them..Comply with all legal instructions.''

Kalaburagi, Mar 11: A suspected coronavirus patient who had returned to Kalaburagi from Saudi Arabia on February 29 passed away today in hospital.

It is said he was admitted to the hospital on March 5 after he showed flu symptoms. But, the family members of the patient had shifted him to Hyderabad from GIMS on Tuesday against the advice of the doctors.

However, the district administration and District Health Officer (DHO) M A Jabbar are waiting for the final report of throat swab of the patient sent for lab test.

The DHO has directed Taluk Health Officer Sharanabasappa Kyatanal to supervise until the final rites of the suspect person were performed.

Kalaburagi Deputy Commissioner B Sharat said the patient died on Tuesday night on his way back to Kalaburagi after the doctor stated that chances of his survival was bleak. "It is still a suspected coronavirus case. We are waiting for the report," he said.

Sharat said he developed severe respiratory problem coupled with cough, cold and fever. "As he was 76-year-old, he failed to respond to the treatment. It is yet to be confirmed if the cause of death was coronavirus," he said.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.